Spinocerebellar ataxia

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Spinocerebellar ataxia
Classification and external resources
Cerebellum (in blue) of the human brain
ICD-10 G11.
ICD-9 334
DiseasesDB 12339
MeSH D020754

Spinocerebellar ataxia (SCA) is a progressive, degenerative,[1] genetic disease with multiple types, each of which could be considered a disease in its own right.

Contents

[edit] Symptoms

Spinocerebellar ataxia (SCA) is one of a group of genetic disorders characterized by slowly progressive incoordination of gait and often associated with poor coordination of hands, speech, and eye movements. Frequently, atrophy of the cerebellum occurs, and different ataxias are known to affect different regions within the cerebellum. [2]

As with other forms of ataxia, SCA results in unsteady and clumsy motion of the body due to a failure of the fine coordination of muscle movements, along with other symptoms.

The symptoms of an ataxia vary with the specific type and with the individual patient. Generally, a person with ataxia retains full mental capacity but may progressively lose physical control.

[edit] Treatment and prognosis

There is no known cure for spinocerebellar ataxia, which is a progressive disease (it gets worse with time), although not all types cause equally severe disability.

Treatments are generally limited to softening symptoms, not the disease itself. The condition can be irreversible. A person with this disease will usually end up needing to use a wheelchair, and eventually they may need assistance to perform daily tasks.

The treatment of incoordination or ataxia, then mostly involves the use of adaptive devices to allow the ataxic individual to maintain as much independence as possible. Such devices may include a cane, crutches, walker, or wheelchair for those with impaired gait; devices to assist with writing, feeding, and self care if hand and arm coordination are impaired; and communication devices for those with impaired speech.

Many patients with hereditary or idiopathic forms of ataxia have other symptoms in addition to ataxia. Medications or other therapies might be appropriate for some of these symptoms, which could include tremor, stiffness, depression, spasticity, and sleep disorders, among others.

Both onset of initial symptoms and duration of disease can be subject to variation. If the disease is caused by a polyglutamine trinucleotide repeat CAG expansion, a longer expansion may lead to an earlier onset and a more radical progression of clinical symptoms.

The following is a list of some, not all, types of Spinocerebellar ataxia. The first ataxia gene was identified in 1993 for a dominantly inherited type. It was called “Spinocerebellar ataxia type 1" (SCA1). Subsequently, as additional dominant genes were found they were called SCA2, SCA3, etc. Usually, the "type" number of "SCA" refers to the order in which the gene was found. At this time, there are at least 29 different gene mutations which have been found (not all listed).

Many SCAs below fall under the category of polyglutamine diseases, which are caused when a disease-associated protein (ie. ataxin-1, ataxin-3, etc.) contains a glutamine repeat beyond a certain threshold. In most dominant polyglutamine diseases, the glutamine repeat threshold is approximately 35, except for SCA3 which is beyond 50. Polyglutamine diseases are also known as "CAG Triplet Repeat Disorders" because CAG is the codon which codes for the amino acid glutamine. Many prefer to refer to these also as polyQ diseases since "Q" is the one-letter reference for glutamine.

SCA Type Average Onset
(Range in Years)
Average Duration
(Range in Years)
What the patient experiences Common origin Problems
with DNA
SCA1[3] (ATXN1) 4th decade
(<10 to >60)
15 years
(10-28)
Hypermetric saccades, slow saccades, upper motor neuron
(note: saccades relates to eye movement)
  CAG repeat, 6p (Ataxin 1)
SCA2[4] (ATXN2) 3rd - 4th decade
(<10 to >60)
10 years
(1-30)
Diminished velocity saccades
areflexia (absence of neurologic reflexes)
Cuba CAG repeat, 12q
SCA3[5] (MJD) (ATXN3) 4th decade
(10-70)
10 years
(1-20)
Also called Machado-Joseph disease (MJD)[6]
Gaze-evoked nystagmus (a rapid, involuntary, oscillatory motion of the eyeball)
upper motor neuron
slow saccades
Azores
(Portugal)
CAG repeat, 14q
SCA4 (PLEKHG4) 4th - 7th decade
(19-72)
Decades areflexia (absence of neurologic reflexes)   Chromosome 16q
SCA5 (SPTBN2) 3rd - 4th decade
(10-68)
>25 years Pure cerebellar   Chromosome 11
SCA6[7] (CACNA1A) 5th - 6th decade
(19-71)
>25 years Downbeating nystagmus, positional vertigo
Symptoms can appear for the first time as late as 65 years old.
  CAG repeat, 19p
Calcium channel gene
SCA7[8] (ATXN7) 3rd - 4th decade
(0.5 - 60)
20 years
(1-45; early onset correlates with shorter duration)
Macular degeneration, upper motor neuron, slow saccades   CAG repeat, 3p (Ataxin 7)
SCA8[9] (IOSCA) 39 yrs
(18-65)
Normal lifespan Horizontal nystagmus (a rapid, involuntary, oscillatory motion of the eyeball)   CTG repeat, 13q
SCA10[10] (ATXN10) 36 years 9 years ataxia, seizures Mexico Chromosome 22q linked
pentanucleotide repeat
SCA11 30 yrs
(15-70)
Normal lifespan Mild, remain ambulatory (able to walk about on one's own)   15q
SCA12[11] (PPP2R2B) 33 yrs
(8-55)
  Head and hand tremor,
akinesia (loss of normal motor function, resulting in impaired muscle movement)
  CAG repeat, 5q
SCA13 Childhood or adulthood depending on mutation Depending on KCNC3 (a kind of gene) Mental retardation   19q
SCA14[12] (PRKCG) 28 yrs
(12-42)
Decades
(1-30)
Myoclonus (a sudden twitching of muscles or parts of muscles, without any rhythm or pattern, occurring in various brain disorders)   19q
SCA16 39 yrs
(20-66)
1-40 years Head and hand tremor   8q
SCA17 (TBP)         CAG repeat, 6q (TATA-binding protein)
SCA19, SCA22     Mild cerebellar syndrome, dysarthria    
SCA25 1.5-39 yrs Unknown ataxia with sensory neuropathy, vomiting and gastrointestinal pain.   2p

Others include SCA18, SCA20, SCA21, SCA23, SCA26, SCA28, and SCA29.

Four X-linked types have been described (302500, 302600, 301790, 301840), but only the first of these has so far been tied to a gene (SCAX1).

[edit] Inheritance

The hereditary ataxias are categorized by mode of inheritance and causative gene or chromosomal locus. The hereditary ataxias can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner.

  • Many types of autosomal dominant cerebellar ataxias are now known for which specific genetic information is available. Synonyms for autosomal dominant cerebellar ataxias (ADCA) used prior to the current understanding of the molecular genetics were Marie's ataxia, inherited olivopontocerebellar atrophy, cerebello-olivary atrophy, or the more generic term "spinocerebellar degeneration." (Spinocerebellar degeneration is a rare inherited neurological disorder of the central nervous system characterized by the slow degeneration of certain areas of the brain. There are three forms of spinocerebellar degeneration: Types 1, 2, 3. Symptoms begin during adulthood.)
  • There are five typical autosomal recessive disorders in which ataxia is a prominent feature: Friedreich ataxia, ataxia-telangiectasia, ataxia with vitamin E deficiency, ataxia with oculomotor apraxia (AOA), spastic ataxia. Disorder Subdivisions: Friedreich's ataxia, Spinocerebellar ataxia, Ataxia telangiectasia, Vasomotor ataxia, Vestibulocerebellar, Ataxiadynamia, Ataxiophemia, Olivopontocerebellar atrophy, and Charcot-Marie-Tooth disease.
  • There have been reported cases where a polyglutamine expansion may lengthen when passed down, which often can result in an earlier age-of-onset and a more severe disease phenotype for individuals who inherit the disease allele. This falls under the category of genetic anticipation.

[edit] Notable cases

Sufferers from the disease include:

[edit] References

  1. ^ spinocerebellar ataxia at Dorland's Medical Dictionary
  2. ^ Genes and Disease at nlm.nih.gov - Gives a concise description of SCA, along with a picture of shrunken degenerated cerebellum.
  3. ^ sca1 at NIH/UW GeneTests
  4. ^ sca2 at NIH/UW GeneTests
  5. ^ sca3 at NIH/UW GeneTests
  6. ^ machado_joseph at NINDS
  7. ^ sca6 at NIH/UW GeneTests
  8. ^ sca7 at NIH/UW GeneTests
  9. ^ sca8 at NIH/UW GeneTests
  10. ^ sca10 at NIH/UW GeneTests
  11. ^ sca12 at NIH/UW GeneTests
  12. ^ sca14 at NIH/UW GeneTests

[edit] External links


Personal tools